LifeCycle Pharma Announces Positive Results from a 12 Month Extension Phase of the Phase 2 Clinical Study of LCP-Tacro™ Once Daily in Stable Liver Transplant Patients
9/29/2009 11:04:14 AM
More...
|
Jim New Steps Down as CEO of LifeCycle Pharma Today
8/31/2009 6:54:33 AM
More...
|
LifeCycle Pharma Announces First Half 2009 Results, Positive Interim Result for LCP-TacroTM in De Novo Liver Patients and Improves the Full Year Outlook with DKK 100 Million
8/20/2009 8:31:50 AM
More...
|
LifeCycle Pharma's Updated Financial Calendar 2009
8/13/2009 9:05:04 AM
More...
|
LifeCycle Pharma Achieved Strong Progress in its Pipeline
5/14/2009 9:27:09 AM
More...
|
LifeCycle Pharma to Host Conference Call Announcing Interim Report for 1st Quarter 2009 – Results from January 1 to March 31, 2009
5/11/2009 10:04:32 AM
More...
|
LifeCycle Pharma Passing of Annual General Meeting - Subsequent Constitution of the Board of Directors
4/24/2009 9:25:18 AM
More...
|
LifeCycle Pharma: Major Shareholder Announcement
4/17/2009 9:09:25 AM
More...
|
Karin Hamberg Steps Down as Executive Vice President at LifeCycle Pharma
4/14/2009 11:44:43 AM
More...
|
LifeCycle Pharma Summons Annual General Meeting
4/8/2009 9:42:09 AM
More...
|
|